Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1977-02-08
1978-03-14
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125R, A61K 3700, C07C10352
Patent
active
040791270
ABSTRACT:
The amino acid sequence of a biologically active polypeptide hormone isolated from calf thymus termed thymosin .alpha..sub.1 has been determined. Thymosin .alpha..sub.1 is a heat stable acidic molecule composed of 28 amino acid residues. This peptide is one of several present in thymosin fraction 5 which participate in the regulation, differentiation and function of thymic dependent lymphocytes (T cells).
REFERENCES:
goldstein, Nature 247, 1974, pp. 11-14.
Goldstein Allan L.
Lai Chun-Yen
Low Teresa L. K.
Wang Su-Sun
Board of Regents of the University of Texas
Gould George M.
Hoffmann-La Roche Inc.
Phillips Delbert R.
Saxe Jon S.
LandOfFree
Thymosin alpha 1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thymosin alpha 1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thymosin alpha 1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2230814